生物技术公司Alloy Therapeutics宣布与艾伯维公司达成一项多年期战略合作。根据协议条款,Alloy Therapeutics将获得一笔首付款,并在向艾伯维交付其专属技术平台后触发额外付款机制。此次合作将整合Alloy Therapeutics的创新平台技术与艾伯维在药物研发领域的专业优势,共同推进新型疗法的开发。
生物技术公司Alloy Therapeutics宣布与艾伯维公司达成一项多年期战略合作。根据协议条款,Alloy Therapeutics将获得一笔首付款,并在向艾伯维交付其专属技术平台后触发额外付款机制。此次合作将整合Alloy Therapeutics的创新平台技术与艾伯维在药物研发领域的专业优势,共同推进新型疗法的开发。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.